Weekly Top News – Psoriasis– January 6, 2020

Stelara (ustekinumab) / J&JStelara patent expiry: January 2024 in EU (Barclays) - Jan 2, 2020 - A subscription to Thomson ONE is required to gain full access to report 68519497; Page no: 8; REPORT TITLE: "Johnson & Johnson: Last minute gift idea? JNJ; Upgrade to overweight”; AUTHOR: Stewart, Kristen, et al; DATE: 12/19/2019AVT02 (adalimumab biosimilar) / Alvotech, Cipla; Humira (adalimumab) / Eisai, AbbVieEfficacy, Safety, and Immunogenicity of AVT02 With Moderate-to-Severe Chronic Plaque Psoriasis (clinicaltrials.gov) - Jan 3, 2020 - P3; N=413; Active, not recruiting; Sponsor: Alvotech Swiss AG; Recruiting --> Active, not recruiting; Initiation date: Feb 2019 --> Dec 2019